An empirical operationalization study of DSM-IV diagnostic criteria for premature ejaculation

References

• American Psychiatric Association. Diagnostic and statistical manual of mental disorders 4th edn. APA, Washington, DC. 1994
   Google Scholar
• Masters W H, Johnson V E. Human sexual response. Little Brown, Boston 1966
   Google Scholar
• Waldinger M D, Berendsen H HG, Blok B FM, et al. Premature ejaculation and serotonergic antidepressant-induced delayed ejaculation: the involvement of the serotonergic system. Behav Brain Res 1998; 92: 111–118
   PubMed Web of Science ®Google Scholar
• Waldinger M D, Rietschel M, Nothen M M, et al. Familial occurrence of primary premature ejaculation. Psychiatr Genetics 1998; 8: 37–40
   PubMed Web of Science ®Google Scholar
• Goodman R E. An assessment of clomipramine (Anafranil) in the treatment of premature ejaculation. J Int Med Res 1980; 8suppl 3): 53–59
   Google Scholar
• Girgis S M, El-Haggen S, El-Hermouzy S. A double blind trial of clomipramine in premature ejaculation. Andrologia 1982; 14: 364–8
   PubMed Web of Science ®Google Scholar
• Althof S E, Levine S B, Corty E W, et al. A double-blind crossover trial of clomipramine for rapid ejaculation in 15 couples. J Clin Psychiatry 1995; 56: 402–7
   PubMed Web of Science ®Google Scholar
• Haensel S M, Rowland D L, Kalian K THK, et al. Clomipramine and sexual function in men with premature ejaculation and controls. J Urol 1996; 156: 1310–5
   PubMed Web of Science ®Google Scholar
• Waldinger M D, Hengeveld M W, Zwinderman A H. Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am J Psychiatry 1994; 151: 1377–9
   PubMed Web of Science ®Google Scholar
• Waldinger M D. Use of psychoactive agents in the treatment of sexual dysfunction. CNS Drugs 1996; 6: 204–216
   Google Scholar
• Waldinger M D, Hengeveld M W, Zwinderman A H. Ejaculation retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study. Br J Urol 1997; 79: 592–5
   PubMedGoogle Scholar
• Waldinger M D, Hengeveld M W, Zwinderman A H, et al. The effect of SSRI antidepressants on ejaculation: a double-blind, randomised, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine and sertraline. J Clin Psychopharmacol 1998; 18: 274–281
   PubMed Web of Science ®Google Scholar
• Mendels J, Camera A, Sikes C. Sertraline treatment for premature ejaculation. J Clin Psychopharmacol 1995; 15: 341–6
   PubMed Web of Science ®Google Scholar
• Kara H, Aydin S, Agargün Y, et al. The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study. J Urol 1996; 156: 1631–2
   PubMed Web of Science ®Google Scholar
• Grenier G, Byers E S. The relationships among ejaculatory control, ejaculatory latency, and attempts to prolong heterosexual intercourse. Arch Sexual Behav 1997; 26: 27–47
   PubMed Web of Science ®Google Scholar
• Grenier G, Byers E S. Rapid ejaculation: a review of conceptual, etiological, and treatment issues. Arch Sexual Behav 1995; 24: 447–72
   PubMed Web of Science ®Google Scholar
• Cooper A J, Magnus R V. A clinical trial of the beta blocker propranolol in premature ejaculation. J Psychosom Res 1984; 28: 331–6
   PubMed Web of Science ®Google Scholar
• Spiess W F, Geer J H, O'Donohue W T. Premature ejaculation: Investigation of factors in ejaculatory latency. J Abnorm Psychol 1984; 93: 242–5
   PubMed Web of Science ®Google Scholar
• Strassberg D S, Mahoney J M, Schaugaard M, et al. The role of anxiety in premature ejaculation: A psychophysiological model. Arch Sex Behav 1990; 19: 251–8
   PubMed Web of Science ®Google Scholar
• Strassberg D S, Kelly M P, Carroll C, et al. The psychophysiological nature of premature ejaculation. Arch. Sex Behav 1987; 16: 327–36
   PubMed Web of Science ®Google Scholar
• LoPiccolo J. Direct treatments of sexual dysfunction in the couple. Handbook of sexology. Selected syndromes and therapy, J Money, H Musaph. Elsevier, New York 1978; Vol 5: 1227–44
   Google Scholar
• Kilmann P R, Auerbach R. Treatments of premature ejaculation and psychogenis impotence: a critical review of the literature. Arch Sex Behav 1979; 8: 81–100
   PubMed Web of Science ®Google Scholar
• Trudel G, Proulx S. Treatments of premature ejaculation by bibliotherapy: an experimental study. Sex Marital Ther 1987; 2: 163–7
   Google Scholar
• Zeiss R A, Christensen A, Levine A G. Treatment for premature ejaculation through male-only groups. J Sex Marital Ther 1978; 4: 139–143
   PubMed Web of Science ®Google Scholar
• Schover L R, Friedman J M, Weiler S J, et al. Multiaxial problem-oriented system for sexual dysfunctions. Arch Gen Psychiatry 1982; 39: 614–9
   PubMed Web of Science ®Google Scholar
• Derogatis L R. SCL-90, Handleiding bij een Multidimensionale Psychopathologie-indicator. (Dutch translation and adaptation), W A Arrindell, J HM Ettema. Swets & Zeitlinger BV, Lisse 1986
   Google Scholar
• Waldinger M D, Olivier B. Selective serotonin reuptake inhibitor-induced sexual dysfunction: clinical and research considerations. Int Clin Psychopharmacology 1998; 13(suppl 6)S27–S33
   PubMedGoogle Scholar
• Waldinger M D (1998) The Psychopharmacotherapy of premature ejaculation. Proceedings of the 8th World Meeting on Impotence Research., AmsterdamThe Netherlands, August 24–28, 1998, E Meuleman, G Lycklamaa Nijeholt, D van der Schueren. Monduzzi Editore, Bologna, 99–102
   Google Scholar
• Waldinger M D, Olivier B. Selective serotonin reuptake inhibitors and sexual side effects: differences in delaying ejaculation. Advances in Predinical and Clinical Psychiatry. fluoxamine established and emerging roles in psychiatric disorders. Excerpta Medica, Milan 1998; Volume 1, (in press).
   Google Scholar